Robert Schlegel
Ratings
0
Nobody has rated this yet. Be the first!
Works
2
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
